Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › TN › Memphis › NPI 1033112230
Supplier

ST Jude Childrens Research Hospital INC

ST Jude Childrens Research Hospital INC was paid $5.07M by Medicaid between Jan 2018 and Nov 2024, across 141 billing codes. Its largest line is 70553, Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences — 13% of everything it billed.

33Billing provider infoST JUDE CHILDRENS RESEARCH HOSPITAL INC
MEMPHIS, TN 38105
33aNPI1033112230assigned 05/23/2005
33bProvider typeClinic Pharmacy
28Total paid$5.07M
24GClaims334,801
24DCodes billed141
24AFirst – last monthJan 2018 – Nov 2024
Box 24A · Dates of service

Paid by month

$0$50K$100K$150K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201860,804$1.06M
201958,941$1.08M
202039,745$660K
202147,495$793K
202245,296$550K
202350,127$568K
2024incomplete32,393$364K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences 13% 2,792 2,288 $664K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 8.5% 53,559 32,492 $432K
P9040 Red blood cells, leukocytes reduced, irradiated, each unit 8.4% 1,316 913 $428K
80053 Comprehensive metabolic panel 8.3% 37,302 22,986 $421K
36430 5.6% 1,609 966 $285K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 3.7% 824 670 $189K
96409 3.5% 1,635 704 $179K
86900 3.5% 4,916 3,152 $176K
83021 3.4% 8,305 6,997 $172K
83735 2.5% 24,394 11,129 $129K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance 2.4% 759 273 $123K
83615 2.3% 20,923 13,909 $118K
129 more codes
85045 2.2% 25,562 $112K
86920 2.0% 801 $102K
86850 1.9% 4,807 $96K
96375 Therapeutic injection; each additional sequential IV push 1.9% 2,232 $94K
84100 1.8% 24,136 $90K
A9585 Injection, gadobutrol, 0.1 ml 1.7% 3,473 $89K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 1.7% 2,171 $87K
86901 1.5% 4,920 $78K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 1.5% 3,155 $77K
80048 Basic metabolic panel (calcium, ionized) 1.2% 4,362 $59K
82248 <1% 9,244 $49K
82728 <1% 3,480 $46K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 1,988 $42K
84550 <1% 11,623 $42K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 290 $39K
J2704 Injection, propofol, 10 mg <1% 10,141 $37K
86922 <1% 444 $34K
82610 <1% 2,857 $32K
36415 Collection of venous blood by venipuncture <1% 8,394 $30K
99213 Doctor's office visit, returning patient (routine) <1% 957 $29K
99214 Doctor's office visit, returning patient (more involved) <1% 704 $28K
92018 <1% 58 $25K
83020 <1% 1,561 $24K
87536 <1% 421 $20K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 182 $19K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 686 $19K
82043 <1% 1,281 $16K
90674 <1% 1,113 $16K
84703 <1% 2,583 $15K
86902 <1% 482 $15K
88184 <1% 94 $15K
82570 <1% 1,653 $14K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 4,929 $13K
36592 <1% 964 $11K
90686 <1% 937 $11K
82784 <1% 997 $9K
86361 <1% 224 $8K
99215 Doctor's office visit, returning patient (complex) <1% 178 $8K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 375 $8K
84439 <1% 1,703 $8K
92567 <1% 591 $8K
90651 <1% 30 $8K
81003 <1% 4,417 $7K
97164 <1% 276 $7K
96361 Intravenous infusion, hydration; each additional hour <1% 111 $7K
86140 <1% 1,982 $7K
80050 General health panel <1% 825 $7K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 39 $6K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 43 $6K
97168 <1% 200 $5K
J9370 Vincristine sulfate, 1 mg <1% 1,011 $5K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 296 $5K
81001 <1% 1,861 $5K
92523 <1% 60 $5K
85027 <1% 1,014 $4K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 1,650 $4K
84156 <1% 1,397 $4K
92250 <1% 188 $4K
87799 <1% 79 $4K
88108 <1% 252 $4K
82533 <1% 261 $4K
0399T <1% 82 $4K
84466 <1% 404 $4K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 2,068 $3K
83002 <1% 358 $3K
J9250 Methotrexate sodium, 5 mg <1% 916 $3K
J7050 Infusion, normal saline solution, 250 cc <1% 2,153 $3K
90661 <1% 171 $3K
J7120 Ringers lactate infusion, up to 1000 cc <1% 1,968 $3K
71046 Radiologic examination, chest; 2 views <1% 63 $3K
93888 <1% 33 $3K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 62 $3K
83540 <1% 557 $3K
62270 <1% 14 $2K
88185 <1% 27 $2K
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml <1% 171 $2K
90620 <1% 19 $2K
89051 <1% 557 $2K
87497 <1% 79 $2K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 66 $2K
36591 <1% 249 $2K
87103 <1% 98 $1K
83001 <1% 151 $1K
76376 <1% 229 $1K
92014 Ophthalmological services: medical examination and evaluation, comprehensive, established patient <1% 180 $937.60
87486 <1% 39 $886.12
87581 <1% 39 $886.12
80061 Lipid panel <1% 99 $867.73
J1720 Injection, hydrocortisone sodium succinate, up to 100 mg <1% 119 $811.21
87040 <1% 96 $697.55
93356 <1% 271 $686.57
86360 <1% 24 $676.44
92133 <1% 29 $657.50
83525 <1% 103 $627.60
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 79 $563.87
86355 <1% 24 $538.10
0202U Oncology (prostate), multianalyte, gene expression profiling <1% 107 $531.36
86357 <1% 24 $528.71
86359 <1% 24 $528.70
86706 <1% 62 $480.63
84443 Thyroid stimulating hormone (TSH) <1% 43 $469.62
J7060 5% dextrose/water (500 ml = 1 unit) <1% 594 $447.20
96411 <1% 18 $405.34
87535 <1% 12 $361.14
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 261 $354.26
90734 <1% 27 $311.80
92552 <1% 29 $272.32
J9100 Injection, cytarabine, 100 mg <1% 103 $226.86
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 74 $199.89
87340 <1% 32 $184.45
82670 <1% 14 $161.04
84305 <1% 24 $160.70
J7030 Infusion, normal saline solution , 1000 cc <1% 226 $151.27
90472 Immunization administration, each additional vaccine (list separately) <1% 14 $145.65
82330 <1% 13 $139.09
90685 <1% 24 $136.26
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 48 $131.58
A4618 Breathing circuits <1% 92 $97.96
J1626 Injection, granisetron hydrochloride, 100 mcg <1% 30 $95.83
86704 <1% 13 $95.22
85730 <1% 18 $70.24
83036 Hemoglobin; glycosylated (A1C) <1% 14 $60.51
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 25 $53.35
92556 <1% 28 $53.10
S0080 Injection, pentamidine isethionate, 300 mg <1% 32 $52.29
85610 <1% 16 $34.56
J9260 Injection, methotrexate sodium, 50 mg <1% 21 $24.09
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 35 $11.45
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 28 $3.64

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialKEEL, PATRICIA (SVP/CFO)
Same official

Other billing entities under KEEL, PATRICIA

Full network →
ProviderLocationPaid
ST Jude Children's Research Hospital, INC.Memphis, TN$1.19M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.